WHO ICTRP trial
Methylphenidat betydning for motorisk indlæring hos patienter med apopleksi
EUCTR2006-002554-29-DK · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-002554-29-DK |
|---|---|
| Public title | Methylphenidat betydning for motorisk indlæring hos patienter med apopleksi |
| Scientific title | Methylphenidat betydning for motorisk indlæring hos patienter med apopleksi |
| Primary sponsor | Hammel neurocenter |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Denmark |
| Conditions | Patients less that 2 months after the first hemorrhagic or ischemic stroke. |
| Interventions | Product Name: Ritalin Pharmaceutical Form: Tablet Concentration unit: g gram(s) Concentration type: equal Concentration number: 0,020- Pharmaceutical form of the placebo: Tablet Route of administration of the placebo: Oral use |
| Registration date | Jun 26, 2006 |
| Target size | 20 |
| Secondary IDs | 2006-1 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: